
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Chiltern has acquired Integrated Development Associates (IDA), a Japanese CRO specializing in integrating Japan and Asia into global drug development.
Chiltern has acquired Integrated Development Associates (IDA), a Japanese CRO specializing in integrating Japan and Asia into global drug development. Under this acquisition, IDA will do business as a subsidiary of Chiltern and be renamed IDA, a Chiltern Company.
Read the full release






